SCHEMBL14865812

SCHEMBL14865812

CCCOCCOCC(O)CSc1ccccc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.46
MAOB P27338 1/20 0.46
BACE1 P56817 1/20 0.43
MAPT P10636 2/20 0.41
HSD17B10 Q99714 2/20 0.39
MTNR1A P48039 3/20 0.39
MTNR1B P49286 3/20 0.39
KMT2A Q03164 2/20 0.38
TSHR P16473 2/20 0.38
MEN1 O00255 1/20 0.38
HPGD P15428 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPK1 P28482 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
ADRB2 P07550 2/20 0.38
ADRB1 P08588 2/20 0.38
ALPL P05186 1/20 0.38
ALPI P09923 1/20 0.38
GAA P10253 1/20 0.38
ALPG P10696 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14865700 0.84 CASR (0.48) BACE1MAPTHSD17B10MTNR1AMTNR1B
SCHEMBL2952028 0.82 MAPT (0.50) MAOAMAOBBACE1MAPTHSD17B10
SCHEMBL2733001 0.78 ALDH1A1 (0.54) MAOAMAOBMAPTMTNR1AMTNR1B
SCHEMBL6166661 0.78 CA1 (0.60) MAOAMAOBBACE1TSHRMAPK1
SCHEMBL25761455 0.76 HPGD (0.68) MAPTHSD17B10KMT2ATSHRMEN1
Alcohol SCHEMBL914156 0.76 MAOA (0.53) MAOAMAOBBACE1MAPTMTNR1A
SCHEMBL1496667 0.76 MAOA (0.53) MAOAMAOBBACE1MAPTMTNR1A
SCHEMBL18826755 0.76 ALDH1A1 (0.56) MAOAMAOBMAPTMTNR1AMTNR1B
SCHEMBL916141 0.75 MAOA (0.56) MAOAMAOBBACE1MAPTMTNR1A
SCHEMBL2950981 0.74 BACE1 (0.45) MAOAMAOBBACE1MAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8530559-B2 Composite of organic compound and copper nanoparticles, composite of organic compound and copper(I) oxide nanoparticles, and methods for producing the composites DIC CORPORATION (JP) 2013-09-10 US disclosed
US-20130095320-A1 COMPOSITE OF ORGANIC COMPOUND AND COPPER NANOPARTICLES, COMPOSITE OF ORGANIC COMPOUND AND COPPER(I) OXIDE NANOPARTICLES, AND METHODS FOR PRODUCING THE COMPOSITES DIC CORPORATION (JP) 2013-04-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130095320-A1 COMPOSITE OF ORGANIC COMPOUND AND COPPER NANOPARTICLES, COMPOSITE OF ORGANIC COMPOUND AND COPPER(I) OXIDE NANOPARTICLES, AND METHODS FOR PRODUCING THE COMPOSITES AOC3, AOC2, CORO1C MAOA 2286/4885MAOB 2184/4885BACE1 2950/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.